Table 2.
Clinicopathological characteristics of the study population.
| Age | Mean ± SD | 66.5 ± 13.2 years | |
| Range (Min–Max) | 38–87 years | ||
| Sex | Male | n = 36 | 71% |
| Female | n = 15 | 29% | |
| Tumor Site | Area H | n = 18 | 35% |
| Area M | n = 6 | 12% | |
| Area L | n = 24 | 47% | |
| ND | n = 3 | 6% | |
| Histologic Subtype | BCC with indolent growth | n = 24 | 47% |
| BCC with aggressive growth | n = 27 | 53% | |
| Tumor Size | >2 cm | n = 7 | 14% |
| <2 cm | n =36 | 71% | |
| ND | n = 8 | 16% |
n = 51; Area H: “mask areas” of face (central face, eyelids, eyebrows, periorbital, nose, lips [cutaneous and vermilion], chin, mandible, preauricular and postauricular skin/sulci, temple, ear), genitalia, hands, and feet; Area M: Cheeks, forehead, scalp, neck, and pretibial; Area L: Trunk and extremities.